A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. For…
A variety of generic pills and capsules. Nenov | Moment | Getty Images Pharmaceutical firms are scrambling to respond to a fresh ultimatum from U.S. President Donald Trump demanding “binding commitments” to lower their drug prices stateside. The White House said Thursday that President Trump had sent letters to 17 major pharmaceutical firms outlining the…
U.S. President Donald Trump speaks to the media during a tour of the Federal Reserve Board building, which is currently undergoing renovations, in Washington, D.C., U.S., July 24, 2025. Kent Nishimura | Reuters I think most would agree that the news cycle has been relentless for most of 2025, but certain stories do seem a…
IonQ CEO Niccolo de Masi told CNBC’s Jim Cramer on Thursday that major advances in quantum computing are fast-approaching. “The era of what’s called quantum supremacy is just around the corner,” De Masi said. “It’s coming in quarters and very low single-digit years, and that’s getting people, obviously, pretty excited about the fact that we’ll…
The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images AstraZeneca on Monday said it plans to invest $50 billion in bolstering its U.S. manufacturing and research capabilities by 2030, becoming the latest pharmaceutical firm to ramp up its stateside spending in the wake of U.S. trade tariffs. The Anglo-Swedish…
City of London skyline with 20 Fenchurch Street, affectionately nicknamed the Walkie Talkie, in London, United Kingdom. Mike Kemp | In Pictures | Getty Images Fundraising from London IPOs slumped to at least a three-decade low in the first half of this year, new data showed on Friday – raising fresh questions about the fading…
